je.st
news
Tag: phase
Climate talks enter next phase, toughest decisions ahead
2015-12-06 02:43:00| Climate Ark Climate Change & Global Warming Newsfeed
Reuters: lobal climate change talks in Paris moved into a new, tougher phase on Saturday as negotiators agreed on a draft accord, albeit one that still leaves hundreds of points of dispute for ministers to resolve next week. While a largely procedural step in the four-year quest for a binding deal to slow global warming, the fact that senior officials from almost 200 nations agreed on a draft marks an advance over the last, failed summit in Copenhagen six years ago. French Foreign Minister Laurent Fabius...
Tags: enter
phase
ahead
decisions
Peregrine Semiconductor Introduces RF Digital Phase Shifter
2015-12-04 04:10:40| rfglobalnet Home Page
Peregrine Semiconductor Corp., founder of RF SOI (silicon on insulator) and pioneer of advanced RF solutions, introduces the UltraCMOS® PE44820, an 8-bit digital phase shifter that covers a 358.6-degree phase range.
Tags: digital
phase
introduces
semiconductor
EDF EN Canada Commissions Rivire-du-Moulin Wind Project Phase 2
2015-12-02 21:38:00| Transmission & Distribution World
EDF EN Canada Inc., a subsidiary of EDF Energies Nouvelles Group, announces the commissioning of Rivire-du-Moulin Phase 2 (200 MW). read more
Tags: canada
project
phase
wind
CBP Announces Phase 3: GSP Retroactive Refund Processing
2015-12-01 09:00:00| Expeditors Newsflash - Americas Edition
Expeditors Newsflash - Americas Edition
Tags: processing
phase
refund
announces
Celyad Treats First Patient of Second Cohort in NKG2D Car T-Cell Phase I Trial
2015-12-01 07:59:13| Semiconductors - Topix.net
Celyad , a leader in the discovery and development of engineered cell therapies, with clinical programs in cardiovascular disease and immuno-oncology, today announced the infusion of the first patient of the second cohort of its Phase I clinical trial evaluating the Company's NKG2D CAR T-Cell therapy in acute myeloid leukaemia and multiple myeloma indications. Dr. Christian Homsy, CEO of Celyad, said : " The treatment of the first patient enrolled in the second cohort of our first-in-man Phase I trial evaluating NKG2D CAR T-Cells demonstrates continued progress in developing our lead immune-oncology program.
Sites : [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] next »